EXTENDED RELEASE SUSPENSION COMPOSITIONS
The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | JAIN, Paras P KUMAR, Ashish JAIN, Satish Kumar SINGH, Romi, Barat SHEAR, Rajesh Srikrishan |
description | The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3137060B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3137060B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3137060B23</originalsourceid><addsrcrecordid>eNrjZNBwjQhx9XNxdVEIcvVxdQx2VQgODQ5w9Qv29PdTcPb3DfAP9gwBsoN5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CxobG5gZmBk5ExEUoA67AkEw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>EXTENDED RELEASE SUSPENSION COMPOSITIONS</title><source>esp@cenet</source><creator>JAIN, Paras P ; KUMAR, Ashish ; JAIN, Satish Kumar ; SINGH, Romi, Barat ; SHEAR, Rajesh Srikrishan</creator><creatorcontrib>JAIN, Paras P ; KUMAR, Ashish ; JAIN, Satish Kumar ; SINGH, Romi, Barat ; SHEAR, Rajesh Srikrishan</creatorcontrib><description>The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231220&DB=EPODOC&CC=EP&NR=3137060B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231220&DB=EPODOC&CC=EP&NR=3137060B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JAIN, Paras P</creatorcontrib><creatorcontrib>KUMAR, Ashish</creatorcontrib><creatorcontrib>JAIN, Satish Kumar</creatorcontrib><creatorcontrib>SINGH, Romi, Barat</creatorcontrib><creatorcontrib>SHEAR, Rajesh Srikrishan</creatorcontrib><title>EXTENDED RELEASE SUSPENSION COMPOSITIONS</title><description>The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBwjQhx9XNxdVEIcvVxdQx2VQgODQ5w9Qv29PdTcPb3DfAP9gwBsoN5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CxobG5gZmBk5ExEUoA67AkEw</recordid><startdate>20231220</startdate><enddate>20231220</enddate><creator>JAIN, Paras P</creator><creator>KUMAR, Ashish</creator><creator>JAIN, Satish Kumar</creator><creator>SINGH, Romi, Barat</creator><creator>SHEAR, Rajesh Srikrishan</creator><scope>EVB</scope></search><sort><creationdate>20231220</creationdate><title>EXTENDED RELEASE SUSPENSION COMPOSITIONS</title><author>JAIN, Paras P ; KUMAR, Ashish ; JAIN, Satish Kumar ; SINGH, Romi, Barat ; SHEAR, Rajesh Srikrishan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3137060B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JAIN, Paras P</creatorcontrib><creatorcontrib>KUMAR, Ashish</creatorcontrib><creatorcontrib>JAIN, Satish Kumar</creatorcontrib><creatorcontrib>SINGH, Romi, Barat</creatorcontrib><creatorcontrib>SHEAR, Rajesh Srikrishan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JAIN, Paras P</au><au>KUMAR, Ashish</au><au>JAIN, Satish Kumar</au><au>SINGH, Romi, Barat</au><au>SHEAR, Rajesh Srikrishan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>EXTENDED RELEASE SUSPENSION COMPOSITIONS</title><date>2023-12-20</date><risdate>2023</risdate><abstract>The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP3137060B2 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | EXTENDED RELEASE SUSPENSION COMPOSITIONS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T02%3A52%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JAIN,%20Paras%20P&rft.date=2023-12-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3137060B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |